Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease
出版年份 2020 全文链接
标题
Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease
作者
关键词
Tocilizumab, COVID-19, Coronavirus disease, Actemra
出版物
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 89, Issue -, Pages 107018
出版商
Elsevier BV
发表日期
2020-09-17
DOI
10.1016/j.intimp.2020.107018
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle
- (2020) Hongzhou Lu et al. JOURNAL OF MEDICAL VIROLOGY
- Pulmonary pathology of early phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer
- (2020) Sufang Tian et al. Journal of Thoracic Oncology
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Rapid and severe Covid‐19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab
- (2020) Gonzalo De Luna et al. AMERICAN JOURNAL OF HEMATOLOGY
- Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
- (2020) J.-M. Michot et al. ANNALS OF ONCOLOGY
- COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
- (2020) Carina Mihai et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
- (2020) Ruggero Capra et al. European Journal of Internal Medicine
- Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
- (2020) Corrado Campochiaro et al. European Journal of Internal Medicine
- Tocilizumab treatment in COVID-19: A single center experience
- (2020) Pan Luo et al. JOURNAL OF MEDICAL VIROLOGY
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
- (2020) Yonggang Zhou et al. National Science Review
- Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab
- (2020) M. Cellina et al. Diagnostic and Interventional Imaging
- Tocilizumab for Treatment of Severe COVID-19 Patients: Preliminary Results from SMAtteo COvid19 REgistry (SMACORE)
- (2020) Marta Colaneri et al. Microorganisms
- Hydroxychloroquine and tocilizumab therapy in COVID-19 patients—An observational study
- (2020) Andrew Ip et al. PLoS One
- Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case–controlled study
- (2020) G Rojas-Marte et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- The Role of Interleukin 6 During Viral Infections
- (2019) Lauro Velazquez-Salinas et al. Frontiers in Microbiology
- Tocilizumab (Actemra)
- (2017) Martin Sheppard et al. Human Vaccines & Immunotherapeutics
- Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus
- (2017) Ben Hu et al. PLoS Pathogens
- Tocilizumab for treating rheumatoid arthritis: an evaluation of pharmacokinetics/pharmacodynamics and clinical efficacy
- (2014) Soken-Nakazawa J Song et al. Expert Opinion on Drug Metabolism & Toxicology
- Blockade of IL-6TransSignaling Attenuates Pulmonary Fibrosis
- (2014) Thanh-Thuy T. Le et al. JOURNAL OF IMMUNOLOGY
- Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation
- (2013) Bart L Haagmans et al. LANCET INFECTIOUS DISEASES
- Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis
- (2010) Nicolas Frey et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Tocilizumab
- (2009) Vicki Oldfield et al. DRUGS
- Tocilizumab: The first interleukin-6-receptor inhibitor
- (2008) Anthony Sebba AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Role of Interleukin-6 in Bleomycin-Induced Lung Inflammatory Changes in Mice
- (2007) Fumitake Saito et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started